Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. When it affects the spleen, it can lead to splenomegaly, abdominal pain, and systemic symptoms such as fever and weight loss. Accurate coding with ICD-10 Code C83.37 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
What is ICD-10 Code C83.37 for Diffuse large B-cell lymphoma, spleen?
ICD-10 Code C83.37 specifically denotes diffuse large B-cell lymphoma localized to the spleen. This aggressive lymphoma can arise de novo or from pre-existing lymphoid tissue. It is crucial to use this code in clinical documentation and billing when a patient presents with symptoms indicative of DLBCL affecting the spleen, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
ICD-10 Code C83.37 – Clinical Definition and Explanation of Diffuse large B-cell lymphoma, spleen
Diffuse large B-cell lymphoma of the spleen is a hematological malignancy that arises from B-lymphocytes. It is characterized by rapid growth and can lead to significant morbidity if not treated promptly. The condition requires immediate medical attention due to its aggressive nature and potential for systemic involvement.
Key Clinical Features:
- Splenomegaly (enlarged spleen) often detected on physical examination or imaging.
- Systemic symptoms such as fever, night sweats, and unexplained weight loss.
- Potential for abdominal pain or discomfort due to splenic enlargement.
- Increased risk of infections due to immunosuppression from the disease.
ICD-10 Code C83.37 for Diffuse large B-cell lymphoma, spleen – SOAP Notes & Clinical Use
ICD-10 Code C83.37 is utilized in SOAP notes to document the presence of diffuse large B-cell lymphoma affecting the spleen. It plays a critical role in capturing the patient's symptoms, assessment findings, and treatment plans, facilitating continuity of care in both acute and chronic settings.
What Does ICD-10 Code C83.37 for Diffuse large B-cell lymphoma, spleen Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C83.37 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse large B-cell lymphoma of the spleen. This ensures comprehensive documentation, supports billing processes, and meets EHR standards for continuity of care.
Treatment Options for ICD-10 Code C83.37 – Diffuse large B-cell lymphoma, spleen
The management of diffuse large B-cell lymphoma of the spleen often necessitates urgent intervention due to its aggressive nature. Treatment typically involves chemotherapy and may require hospitalization.
Antibiotic Therapy:
- Not applicable as DLBCL is not an infectious condition; however, prophylactic antibiotics may be considered in immunocompromised patients.
Supportive Care:
- Management of symptoms such as pain and nausea.
- Supportive transfusions for anemia or thrombocytopenia.
- Nutritional support to address weight loss and cachexia.
Infection Control:
- Implement standard precautions to prevent infections in immunocompromised patients.
- Monitor for signs of infection and initiate prompt treatment as necessary.
How to Document Symptoms of Diffuse large B-cell lymphoma, spleen (ICD-10 C83.37) in SOAP Notes
Subjective:
- Patient reports abdominal pain and discomfort.
- History of unexplained weight loss over the past month.
- Complaints of night sweats and fatigue.
- No prior history of lymphoma or significant medical conditions.
Objective:
- Physical examination reveals splenomegaly.
- Laboratory tests show elevated lactate dehydrogenase (LDH).
- Imaging studies confirm enlarged spleen with no other lymphadenopathy.
- Vital signs stable, but patient appears fatigued.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Diffuse large B-cell lymphoma, spleen (ICD-10 Code C83.37)
Assessment:
- Diagnosis: Diffuse large B-cell lymphoma, spleen, classified as aggressive.
- ICD-10 Code: C83.37.
- Contributing factors include splenomegaly and systemic symptoms.
- Patient's immunocompromised status may complicate treatment.
Plan:
- Initiate chemotherapy regimen as per oncology guidelines.
- Consider referral to hematology/oncology for specialized care.
- Educate patient on symptoms of infection and when to seek care.
- Schedule follow-up appointments for monitoring treatment response.
Treatment & Plan Section for ICD-10 Code C83.37 – Diffuse large B-cell lymphoma, spleen
- First-line treatment typically includes R-CHOP chemotherapy regimen.
- Non-pharmacologic strategies include nutritional support and pain management.
- Monitoring for treatment response through imaging and laboratory tests.
- Follow-up visits to assess for complications and adjust treatment as necessary.
Using ICD-10 Code C83.37 for Diffuse large B-cell lymphoma, spleen in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
- Use C83.37 in appropriate clinical settings, including inpatient and outpatient care.
- Align treatment plans with clinical guidelines to support justified billing.
- Include relevant CPT codes that correspond to the services provided.
Related ICD-10 Codes Often Used with Diffuse large B-cell lymphoma, spleen
- C83.30 – Diffuse large B-cell lymphoma, unspecified site
- C83.31 – Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
- C83.32 – Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb
- C83.33 – Diffuse large B-cell lymphoma, lymph nodes of mediastinum
- C83.34 – Diffuse large B-cell lymphoma, lymph nodes of abdomen
ICD-10 Code C83.37 in Medical Billing and Insurance for Diffuse large B-cell lymphoma, spleen
ICD-10 Code C83.37 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
- Use C83.37 in inpatient settings where aggressive treatment is required.
- Ensure that all chart elements, including patient history and physical exam findings, are complete.
- Review coding guidelines to ensure compliance with payer requirements.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 77021 | CT scan of abdomen with contrast. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.37 for Diffuse large B-cell lymphoma, spleen
What are the common symptoms of diffuse large B-cell lymphoma?
Common symptoms include splenomegaly, abdominal pain, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and increased susceptibility to infections.
How is diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymphoid tissue. Laboratory tests may also be performed to assess overall health and disease progression.
What treatment options are available for diffuse large B-cell lymphoma?
Treatment usually involves chemotherapy, often with a regimen such as R-CHOP. Radiation therapy may also be considered in certain cases, and supportive care is essential for managing symptoms.
Is diffuse large B-cell lymphoma curable?
Diffuse large B-cell lymphoma can be curable, especially when diagnosed early and treated promptly. The prognosis varies based on factors such as the patient's overall health and response to treatment.
